| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25a9338aef579b9f0be857fefcec9e93 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6056 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08 |
| filingDate |
1990-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e43eb31a82e0adce806633e4bd3e02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4a07243c08584c15b92d7028bc42380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33c9910aa7ce804749e82389f448b167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7278ce924f8c7533f8eeaefb2fb977c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826bca629e916433195d9a012157dbe8 |
| publicationDate |
1991-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9109619-A1 |
| titleOfInvention |
Pharmaceutical compositions containing antigen-antibody complexes and uses therefor |
| abstract |
A pharmaceutical composition suitable for administration to human beings in the prevention or treatment of immunologic disorders includes: an immune complex of an antigen and a purified antibody specific thereto, the antigen being selected from a group consisting of antigens that cause pathogenic immunologic reactions in autoimmune disease and graft rejections, and the antigen and antibody being present in a ratio whereby the antibody blocks essentially all binding sites of the antigen; and a pharmacologically acceptable carrier or diluent. The invention also provides a method of administering the composition for treatment of autoimmune disease and treatment or prevention of graft rejections. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5620686-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017218677-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9120874-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8182983-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1653999-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100591776-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1653999-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8110347-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0117536-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011218660-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9814203-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0117536-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005016379-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133688-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9796777-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7960126-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9206120-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6063371-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2440528-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9688746-B2 |
| priorityDate |
1990-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |